Optiscan Imaging (OIL.AX) Stock Price
Optiscan Imaging Price
Revenue at Optiscan Imaging has contracted by 8.1% per year over the past 19 years to 952,000.00 AUD. Optiscan Imaging's net margin stands at -663.0%, down from -239.1% several years earlier. The stock trades about 88% above its 52-week low.
Optiscan Imaging stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Optiscan Imaging over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Optiscan Imaging stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Optiscan Imaging's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Optiscan Imaging Price |
|---|---|
| 9/8/2026 | 0.15 AUD |
| 9/7/2026 | 0.15 AUD |
| 9/4/2026 | 0.15 AUD |
| 9/3/2026 | 0.14 AUD |
| 9/2/2026 | 0.14 AUD |
| 9/1/2026 | 0.15 AUD |
| 8/31/2026 | 0.15 AUD |
| 8/28/2026 | 0.16 AUD |
| 8/27/2026 | 0.16 AUD |
| 8/26/2026 | 0.17 AUD |
| 8/25/2026 | 0.17 AUD |
| 8/24/2026 | 0.17 AUD |
| 8/21/2026 | 0.17 AUD |
| 8/20/2026 | 0.17 AUD |
| 8/19/2026 | 0.16 AUD |
| 8/18/2026 | 0.16 AUD |
| 8/17/2026 | 0.17 AUD |
| 8/14/2026 | 0.17 AUD |
| 8/13/2026 | 0.18 AUD |
| 8/12/2026 | 0.19 AUD |
| 8/11/2026 | 0.19 AUD |
| 8/10/2026 | 0.18 AUD |
| 8/7/2026 | 0.17 AUD |
| 8/6/2026 | 0.16 AUD |
| 8/5/2026 | 0.16 AUD |
| 8/4/2026 | 0.16 AUD |
| 8/3/2026 | 0.15 AUD |
| 7/31/2026 | 0.14 AUD |
| 7/30/2026 | 0.15 AUD |
| 7/29/2026 | 0.15 AUD |
Optiscan Imaging Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Optiscan Imaging Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM AUD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM AUD |
| EBITM AUD |
| EBIT MARGIN% |
| NET INCOMEM AUD |
| NET INCOME GROWTH% |
| SHARESM |
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | – | – | – | – | – | – | 1.00 | 2.00 | 1.00 | 1.00 | – | 1.00 | 1.00 | 1.00 | – |
| -50.00 | – | – | – | – | – | – | – | 100.00 | -50.00 | – | – | – | – | – | – |
| 100.00 | – | – | – | – | – | – | 100.00 | 50.00 | 100.00 | 100.00 | – | -100.00 | 100.00 | 100.00 | – |
| 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | -1.00 | 1.00 | 1.00 | 1.00 |
| -2.00 | – | -2.00 | – | -1.00 | -1.00 | -1.00 | -2.00 | -1.00 | -2.00 | -1.00 | -2.00 | -4.00 | -4.00 | -6.00 | -6.00 |
| -200.00 | – | – | – | – | – | – | -200.00 | -50.00 | -200.00 | -100.00 | – | -400.00 | -400.00 | -600.00 | – |
| -1.00 | – | -2.00 | – | -1.00 | -1.00 | -1.00 | -2.00 | -2.00 | -2.00 | -1.00 | -2.00 | -4.00 | -4.00 | -6.00 | -6.00 |
| -83.33 | – | – | – | – | – | – | 100.00 | – | – | -50.00 | 100.00 | 100.00 | – | 50.00 | – |
| 122.75 | 129.71 | 132.12 | 156.06 | 163.73 | 193.84 | 221.00 | 333.53 | 414.92 | 433.71 | 484.08 | 583.16 | 631.11 | 640.43 | 828.58 | 841.06 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Optiscan Imaging generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Optiscan Imaging retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Optiscan Imaging's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Optiscan Imaging has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Optiscan Imaging's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Optiscan Imaging stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Optiscan Imaging Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Optiscan Imaging business model & stock analysis
Optiscan Imaging SWOT Analysis
Strengths
1. Cutting-edge imaging technology: Optiscan Imaging Ltd possesses advanced imaging technology, allowing them to provide high-resolution and accurate imaging solutions.
2. Strong patent portfolio: The company holds a significant number of patents, providing them with a competitive advantage and protecting their innovative products.
3. Established brand reputation: Optiscan Imaging Ltd has built a solid reputation for delivering reliable and high-quality imaging products, earning trust from customers and industry experts.
Weaknesses
1. Limited market presence: Despite their strengths, Optiscan Imaging Ltd faces challenges in terms of market reach, particularly in expanding their customer base beyond their current target segments.
2. Dependency on key suppliers: The company relies heavily on a few suppliers for critical components, which exposes them to potential disruptions in the supply chain.
3. Relatively small R&D budget: Optiscan Imaging Ltd's R&D budget is comparatively smaller than some competitors, limiting their ability to invest in new product development and innovation.
Opportunities
1. Increasing demand for medical imaging: The healthcare industry's growing need for advanced imaging solutions presents an opportunity for Optiscan Imaging Ltd to expand its market share and revenue.
2. Emerging markets: Optiscan Imaging Ltd can explore untapped markets in developing regions, where the adoption of advanced medical technology is on the rise.
3. Partnerships and collaborations: Collaborating with research institutions, medical centers, and industry partners can enhance Optiscan Imaging Ltd's research capabilities and open doors to new technological advancements.
Threats
1. Intense competition: Optiscan Imaging Ltd operates in a highly competitive market with both established players and new entrants, increasing the pressure to differentiate and innovate.
2. Evolving regulations: Changing regulations and compliance requirements in the healthcare industry can pose challenges and increase the complexity of product development and market entry.
3. Technological advancements: Rapid advancements in imaging technology may require substantial investments to keep up with the pace of innovation, potentially straining Optiscan Imaging Ltd's resources.
Optiscan Imaging Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Optiscan Imaging historical P/E ratio, EBIT multiple, and P/S ratio
Optiscan Imaging annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Optiscan Imaging shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Optiscan Imaging shareholder structure
| % | Name |
|---|---|
27.61018% | |
1.05819% |
Optiscan Imaging Beneficial Ownership Filings (SEC 13D/G)
Optiscan Imaging Executives and Management Board
7 members · avg. age 62 · 29 % women
Prof. Camile Farah
Chief Executive Officer, Managing Director, Executive Director · since 2021
408,966.00 AUD
Management
Mr. Brendan Fafiani
Chief Operating Officer
Ms. Elissa Hansen
Company Secretary
Board of Directors
Mr. Robert Cooke (62)
Non-Executive Chairman of the Board
Ms. Karen Borg
Non-Executive Director
Mr. Ron Song
Non-Executive Director
Mr. Sean Gardiner
Non-Executive Director
Optiscan Imaging Supply Chain
Optiscan Imaging Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.80 | 0.45 | 0.63 | ||
| 2 | -0.76 | -0.64 | 0.32 |
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.18 | -0.09 | 0.10 |
Frequently asked questions about Optiscan Imaging
The business model of Optiscan Imaging Ltd focuses on developing and commercializing advanced medical imaging technologies. The company specializes in the design and manufacture of confocal laser endomicroscopes, which are used in various medical applications. Optiscan Imaging aims to improve the diagnosis and treatment of diseases through their innovative imaging solutions. By leveraging their expertise in advanced imaging technologies, the company aims to provide healthcare professionals with high-quality and real-time cellular imaging during medical procedures. Optiscan Imaging Ltd's business model is centered around offering cutting-edge medical imaging technologies that deliver precise and detailed cellular imaging for improved patient outcomes.
Optiscan Imaging Ltd is primarily active in the medical technology and healthcare industries.
The main competitors of Optiscan Imaging Ltd in the market include companies such as Carl Zeiss Meditec AG, NIDEK CO., LTD., and Topcon Corporation.
Optiscan Imaging Ltd is a renowned company specializing in medical imaging technologies. Established in [year], Optiscan has achieved significant milestones in the field of diagnostic imaging. The company is known for its innovative optical imaging systems, such as confocal microscopy, which provide high-resolution cellular images for diagnostic purposes. Optiscan Imaging Ltd has a rich history of research and development, consistently striving to push the boundaries of medical imaging. With its advanced imaging solutions, Optiscan continues to contribute to the progression of healthcare.
Optiscan Imaging Ltd has achieved several significant milestones. The company successfully developed and patented a revolutionary confocal endomicroscopy technology, which enables real-time, high-resolution imaging of living tissue. Optiscan Imaging Ltd also received clearance from the U.S. Food and Drug Administration (FDA) for its confocal endomicroscopy system, facilitating its entry into the American market. Furthermore, the company collaborated with renowned medical institutions and researchers worldwide to conduct clinical studies and validate the efficacy of its imaging technology. Optiscan Imaging Ltd's relentless dedication to innovation and research has positioned it as a leader in the field of real-time tissue imaging.
Optiscan Imaging Ltd is primarily present in Australia.
Optiscan Imaging Ltd is a company known for its strong commitment to innovation and excellence in medical imaging. With a vision to improve patient outcomes, Optiscan prides itself on providing cutting-edge solutions for real-time cellular imaging. The company's corporate philosophy revolves around leveraging advanced technology to enhance diagnostic accuracy and enhance the effectiveness of medical procedures. Optiscan Imaging Ltd values integrity, collaboration, and a customer-centric approach, ensuring that their products and services meet the evolving needs of the medical community. By prioritizing research and development, Optiscan aims to revolutionize the field of medical imaging, while maintaining a steadfast dedication to quality and patient care.
Converted at the current exchange rate, the Optiscan Imaging share trades at 0.09 EUR (0.15 AUD).
The Optiscan Imaging share (OIL.AX) is listed on 1 stock exchanges, including: ASX (OIL.AX).
Optiscan Imaging Ltd is a leading provider of high-quality microscope systems and components for scientific research, medical diagnostics, and industrial testing and quality assurance. The company was founded in Melbourne, Australia in 1994 and has since expanded its operations worldwide. Today, Optiscan Imaging is a global company that delivers innovative technologies and products to meet the needs of its customers in various industries.
The revenue cannot currently be calculated for Optiscan Imaging.
The profit cannot currently be calculated for Optiscan Imaging.
The P/E ratio cannot be calculated for Optiscan Imaging at the moment.
The P/S cannot be calculated for Optiscan Imaging currently.
The Eulerpool Quality Score for Optiscan Imaging is 3/10.
The ISIN of Optiscan Imaging is AU000000OIL4. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Optiscan Imaging is 932111. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Optiscan Imaging is OIL.AX. The ticker symbol is used to trade Optiscan Imaging shares on the stock exchange.
Optiscan Imaging paid dividends every year for the past 0 years.
Optiscan Imaging is assigned to the 'Health' sector.
The dividends of Optiscan Imaging are distributed in AUD.
Optiscan Imaging stock
Optiscan Imaging Peer Group
Optiscan Imaging Ticker
Optiscan Imaging FIGI
All fundamentals and in-depth analysis of Optiscan Imaging
Our stock analysis for Optiscan Imaging stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Optiscan Imaging. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.